Previous studies have found an association between MASP-2 expression and cancer [71,72,73]; MASP-2 expression significantly correlates with late clinical stage and nodal metastasis, thus indicating its role in cancer progression and aggressive tumor behavior in esophageal SCC [71]. Here, MASP2 is linked to cancer.